1. MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management
   Konstantinos I Papadopoulos et al, 2023, World Journal of Diabetes CrossRef
2. MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy
   Ruxandra Florentina Ionescu et al, 2021, Journal of Medicine and Life CrossRef
3. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204
   Yanyan Yang et al, 2017, Expert Opinion on Therapeutic Patents CrossRef
4. ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects
   Kanika Vasudeva et al, 2020, NeuroMolecular Medicine CrossRef
5. Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness
   Guanghong Jia et al, 2018, Hypertension CrossRef
6. MicroRNAs in Cardiac Hypertrophy
   Nadine Wehbe et al, 2019, International Journal of Molecular Sciences CrossRef
7. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases
   Guoan Zhao, 2018, Journal of Medical Genetics CrossRef
8. Epigenetic miRNA Mediated Regulation of RAS in Cardiovascular Diseases
   Aylin Caliskan et al, 2023, The Renin Angiotensin System in Cardiovascular Disease CrossRef
9. microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
   Claudio de Lucia et al, 2017, Frontiers in Medicine CrossRef
10. MicroRNA as a Therapeutic Target in Cardiac Remodeling
    Chao Chen et al, 2017, BioMed Research International CrossRef
11. The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
    Michaela Adamcova et al, 2021, International Journal of Molecular Sciences CrossRef
12. The Epigenetic Machinery in Vascular Dysfunction and Hypertension
    Emile Levy et al, 2017, Current Hypertension Reports CrossRef
13. Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis
    Rachel M. Golonka et al, 2021, Current Hypertension Reports CrossRef
14. El rol de los microRNAs en el desarrollo de la insuficiencia cardiaca
    Eduardo Acosta-Torres, 2021, Cardiovascular and Metabolic Science CrossRef
15. MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats
    Shunchang Li et al, 2022, Frontiers in Endocrinology CrossRef
16. The Protective Effect of Qishen Granule on Heart Failure after Myocardial Infarction through Regulation of Calcium Homeostasis
    Xiaomin Yang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
17. Silencing of circCacna1c Inhibits ISO-Induced Cardiac Hypertrophy through miR-29b-2-5p/NFATc1 Axis
    Peilei Lu et al, 2023, Cells CrossRef
18. New role of TRPM4 channel in the cardiac excitation-contraction coupling in response to physiological and pathological hypertrophy in mouse
    Christophe Hedon et al, 2021, Progress in Biophysics and Molecular Biology CrossRef
19. Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C
    Jiangang Wang et al, 2021, Journal of Molecular and Cellular Cardiology CrossRef
20. MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1
    Dongyun Li et al, 2022, Bioengineered CrossRef
21. The role of microRNAs in heart failure
    Hongjiang Wang et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
22. Role of MicroRNA in Endothelial Dysfunction and Hypertension
    Miruna Nemecz et al, 2016, Current Hypertension Reports CrossRef
23. Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension
    Christiana Leimena et al, 2018, International Journal of Molecular Sciences CrossRef